855565443	855565443	CD	B-NP	O
|	|	NN	I-NP	O
REH	REH	NN	I-NP	O
|	|	NN	I-NP	O
08530249	08530249	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
927152	927152	CD	B-NP	O
|	|	CC	I-NP	O
3/5/1990	3/5/1990	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/23/1990	11/23/1990	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/3/1990	1/3/1990	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
39	39	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
Wark	Wark	NNP	I-NP	O
Na	Na	NNP	I-NP	O
Bo	Bo	NNP	I-NP	O
female	female	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
discoid	discoid	JJ	B-NP	O
lupus	lupus	NN	I-NP	O
and	and	CC	I-NP	O
pericarditis	pericarditis	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
after	after	IN	B-PP	O
having	have	VBG	B-VP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	I-NP	O
Plaquenil	Plaquenil	NN	I-NP	O
discontinued	discontinue	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
first	first	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
discoid	discoid	JJ	B-NP	O
lupus	lupus	NN	I-NP	O
in	in	IN	B-PP	O
1983	1983	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
years	year	NNS	I-NP	O
developed	develop	VBD	B-VP	O
arthralgias	arthralgia	NNS	B-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
joints	joint	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	I-NP	O
Motrin	Motrin	NN	I-NP	O
and	and	CC	I-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1985	1985	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
pleuritic	pleuritic	JJ	B-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
at	at	IN	B-PP	O
Westten	Westten	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
pericarditis	pericarditis	NN	B-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
pericardiocentesis	pericardiocentesis	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1988	1988	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Arthritis	Arthritis	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Goerlitz	Goerlitz	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
noted	note	VBD	B-VP	O
a	a	DT	B-NP	O
discoid	discoid	JJ	I-NP	O
lupus	lupus	NN	I-NP	O
on	on	IN	B-PP	O
examination	examination	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
sedimentation	sedimentation	NN	B-NP	O
rate	rate	NN	I-NP	O
85	85	CD	I-NP	O
,	,	,	O	O
CH-50	CH-50	NN	B-NP	O
178	178	CD	I-NP	O
,	,	,	O	O
VNA	VNA	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
160	160	CD	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
anti-double-stranded	anti-double-stranded	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
positive	positive	JJ	I-NP	B-protein
Smith/anti-Smith	Smith/anti-Smith	JJ	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Plaquenil	Plaquenil	NN	B-NP	O
200	200	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
plus	plus	CC	O	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Naprosyn	Naprosyn	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lupus	lupus	NN	I-NP	O
flare	flare	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
30	30	CD	I-NP	O
q	q	NN	I-NP	O
am	am	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
in	in	IN	B-PP	O
24	24	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
the	the	DT	B-NP	O
steroids	steroid	NNS	I-NP	O
were	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
off	off	RP	B-PRT	O
and	and	CC	O	O
discontinued	discontinue	VBN	B-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
restarted	restart	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
another	another	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
23	23	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
brain	brain	NN	I-NP	O
magnetic	magnetic	JJ	I-NP	O
resonance	resonance	NN	I-NP	O
imaging	imaging	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
21	21	CD	B-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
pericardial	pericardial	JJ	B-NP	O
thickening	thickening	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
constriction	constriction	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
prior	prior	JJ	B-NP	O
pericarditis	pericarditis	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
occasional	occasional	JJ	B-NP	O
flares	flare	NNS	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
medical	medical	JJ	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
Plaquenil	Plaquenil	NN	B-NP	O
200	200	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	I-VP	O
tid	tid	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
Motrin	Motrin	NN	B-NP	O
800	800	CD	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
again	again	RB	B-ADVP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
pulsus	pulsus	NN	I-NP	O
paradoxus	paradoxus	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
change	change	NN	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
slight	slight	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
size	size	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
30	30	CD	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
with	with	IN	B-PP	O
codeine	codeine	NN	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
16	16	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pericardial	pericardial	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
arthralgias	arthralgia	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
discontinuing	discontinue	VBG	B-VP	O
her	her	PRP$	B-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
Plaquenil	Plaquenil	NN	I-NP	O
and	and	CC	I-NP	O
prednisone	prednisone	NN	I-NP	O
restarted	restart	VBD	B-VP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	B-protein
3	3	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
and	and	CC	I-NP	O
Plaquenil	Plaquenil	NN	I-NP	O
increased	increase	VBD	B-VP	O
stomachaches	stomachache	NNS	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
the	the	DT	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	O	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
sharp	sharp	JJ	B-ADJP	O
,	,	,	O	O
increases	increase	VBZ	B-VP	O
with	with	IN	B-PP	O
cough	cough	NN	B-NP	O
or	or	CC	O	O
deep	deep	JJ	B-NP	O
breaths	breath	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
or	or	CC	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
or	or	CC	O	O
syncope	syncope	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	I-NP	O
chills	chill	NNS	I-NP	O
or	or	CC	I-NP	O
melena	melena	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
increasing	increase	VBG	I-VP	O
joint	joint	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
with	with	IN	B-PP	O
Dilantin	Dilantin	NN	B-NP	B-protein
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
L-thyroxine	L-thyroxine	NN	B-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
without	without	IN	B-PP	O
prior	prior	JJ	B-NP	O
work-up	work-up	NN	I-NP	O
,	,	,	O	O
thoracic	thoracic	JJ	B-NP	O
spine	spine	NN	I-NP	O
compression	compression	NN	I-NP	O
fractures	fracture	NNS	I-NP	O
,	,	,	O	O
gastritis	gastritis	NN	B-NP	O
questionably	questionably	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
Naprosyn	Naprosyn	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
were	be	VBD	B-VP	O
Plaquenil	Plaquenil	NNP	B-NP	O
200	200	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Motrin	Motrin	NN	B-NP	O
80	80	CD	I-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
q	q	NN	I-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
Dilantin	Dilantin	NN	B-NP	O
400	400	CD	I-NP	O
q	q	NN	I-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
L-thyroxine	L-thyroxine	NN	B-NP	O
0.2	0.2	CD	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
225	225	CD	I-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
Diprosone	Diprosone	NN	B-NP	O
Ointment	Ointment	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
or	or	CC	I-VP	O
drink	drink	VB	I-VP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
collagen	collagen	NN	B-NP	B-protein
vascular	vascular	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
mother	mother	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
Hispanic	Hispanic	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
mild	mild	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Temperature	Temperature	NN	B-NP	O
was	be	VBD	B-VP	O
99	99	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
130/70	130/70	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
18	18	CD	B-NP	O
,	,	,	O	O
pulsus	pulsus	NN	B-NP	O
paradoxus	paradoxus	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
.	.	.	O	O

Skin	Skin	NNP	B-NP	O
showed	show	VBD	B-VP	O
numerous	numerous	JJ	B-NP	O
discoid	discoid	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
scalp	scalp	NN	I-NP	O
,	,	,	I-NP	O
face	face	NN	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
forearm	forearm	NN	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
with	with	IN	B-PP	O
patchy	patchy	NN	B-NP	O
alopecia	alopecia	NN	I-NP	O
.	.	.	O	O

Head	Head	RB	B-ADVP	O
,	,	,	O	O
eyes	eye	NNS	B-NP	O
,	,	,	O	O
ears	ear	NNS	B-NP	O
,	,	,	O	O
nose	nose	NN	B-NP	O
and	and	CC	I-NP	O
throat	throat	NN	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
adenopathy	adenopathy	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
I/VI	I/VI	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-NP	O
no	no	DT	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Back	Back	RB	B-ADVP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
costovertebral	costovertebral	JJ	I-NP	O
angle	angle	NN	I-NP	O
or	or	CC	O	O
spinal	spinal	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
is	be	VBZ	B-VP	O
10	10	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
tip	tip	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	JJ	B-NP	O
negative	negative	JJ	I-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
brown	brown	JJ	I-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
external	external	JJ	B-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
without	without	IN	B-PP	O
cords	cord	NNS	B-NP	O
or	or	CC	O	O
Homan	Homan	NNP	B-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
cranial	cranial	JJ	I-NP	O
nerve	nerve	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
motor	motor	NN	B-NP	O
,	,	,	O	O
sensory	sensory	NN	B-NP	O
,	,	,	O	O
coordination	coordination	NN	B-NP	O
and	and	CC	O	O
deep	deep	JJ	B-NP	O
tendon	tendon	NN	I-NP	O
reflexes	reflex	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
slight	slight	JJ	B-NP	O
slowing	slowing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
relaxation	relaxation	NN	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
reflexes	reflex	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
asymmetric	asymmetric	JJ	I-NP	O
synovial	synovial	NN	I-NP	O
thickening	thicken	VBG	B-VP	O
with	with	IN	B-PP	O
slightly	slightly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
most	most	RBS	B-ADVP	O
notably	notably	RB	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
elbow	elbow	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
metacarpophalangeal	metacarpophalangeal	JJ	I-NP	O
joint	joint	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
carpal	carpal	JJ	B-NP	O
,	,	,	I-NP	O
bilateral	bilateral	JJ	I-NP	O
knees	knee	NNS	I-NP	O
and	and	CC	I-NP	O
ankles	ankle	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CK	CK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
76	76	CD	B-NP	O
.	.	.	O	O

Dilantin	Dilantin	NN	B-NP	O
level	level	NN	I-NP	O
5.6	5.6	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
4.7	4.7	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
30	30	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
352	352	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
mean	mean	JJ	B-NP	O
corpuscular	corpuscular	JJ	I-NP	O
volume	volume	NN	I-NP	O
83	83	CD	I-NP	O
,	,	,	O	O
ESR	ESR	NNP	B-NP	O
88	88	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
showed	show	VBD	B-VP	O
specific	specific	JJ	B-NP	O
gravity	gravity	NN	I-NP	O
1.026	1.026	CD	I-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
white	white	JJ	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
red	red	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
granular	granular	JJ	I-NP	O
casts	cast	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
increased	increase	VBN	B-NP	O
heart	heart	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
multiple	multiple	JJ	B-NP	O
thoracic	thoracic	JJ	I-NP	O
compression	compression	NN	I-NP	O
fractures	fracture	NNS	I-NP	O
and	and	CC	I-NP	O
osteopenia	osteopenia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
premature	premature	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
contractions	contraction	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
70	70	CD	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
45	45	CD	I-NP	O
degree	degree	NN	I-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
T-wave	T-wave	JJ	B-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
and	and	CC	O	O
V2	V2	NN	B-NP	O
through	through	IN	B-PP	O
V3	V3	NN	B-NP	B-protein
without	without	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PR	PR	NN	I-NP	B-protein
or	or	CC	I-NP	O
ST	ST	NN	I-NP	B-protein
segments	segment	NNS	I-NP	I-protein
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
voltages	voltage	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Problem	Problem	NNP	B-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
was	be	VBD	B-VP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
pericardial	pericardial	JJ	I-NP	O
pain	pain	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
and	and	CC	I-NP	O
Plaquenil	Plaquenil	NN	I-NP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
happened	happen	VBD	B-VP	O
numerous	numerous	JJ	B-NP	O
times	time	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
pericardial	pericardial	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
indentation	indentation	NN	I-NP	O
or	or	CC	I-NP	O
compromise	compromise	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Plaquenil	Plaquenil	NN	I-NP	O
200	200	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
prednisone	prednisone	NN	B-NP	O
30	30	CD	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
in	in	IN	B-PP	O
that	that	DT	B-NP	O
regard	regard	NN	I-NP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	O
#	#	#	I-NP	O
2	2	CD	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
hematocrit	hematocrit	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
probably	probably	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
hydration	hydration	NN	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
went	go	VBD	B-VP	O
from	from	IN	B-PP	O
31	31	CD	B-NP	O
to	to	TO	B-PP	O
27	27	CD	B-NP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
guaiacs	guaiac	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
between	between	IN	B-PP	O
27	27	CD	B-NP	O
and	and	CC	I-NP	O
30	30	CD	I-NP	O
without	without	IN	B-PP	O
transfusions	transfusion	NNS	B-NP	O
or	or	CC	O	O
further	further	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
Coombs	Coombs	NNP	I-NP	O
test	test	NN	I-NP	O
sent	sent	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
mildly	mildly	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
folate	folate	NN	B-NP	O
and	and	CC	I-NP	O
iron	iron	NN	I-NP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	B-protein
#	#	#	I-NP	I-protein
3	3	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
hematuria	hematuria	NN	B-NP	O
and	and	CC	I-NP	O
pyuria	pyuria	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
and	and	CC	O	O
urine	urine	NN	B-NP	O
gram	gram	NN	I-NP	O
stain	stain	NN	I-NP	O
were	be	VBD	B-VP	O
both	both	CC	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
24-hour	24-hour	JJ	I-NP	O
urine	urine	NN	I-NP	O
collection	collection	NN	I-NP	O
for	for	IN	B-PP	O
protein	protein	NN	B-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
potential	potential	JJ	B-NP	O
lupus	lupus	NN	I-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kidney	kidney	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
for	for	IN	B-PP	O
FOLLOW-UP	FOLLOW-UP	NN	B-NP	B-protein
in	in	IN	B-PP	O
Rheumatology	Rheumatology	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Grondin	Grondin	NNP	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
included	include	VBD	B-VP	O
Plaquenil	Plaquenil	NN	B-NP	O
200	200	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
20	20	CD	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Dilantin	Dilantin	NN	B-NP	O
400	400	CD	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
L-thyroxine	L-thyroxine	NN	B-NP	O
0.2	0.2	CD	I-NP	O
q	q	NN	I-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
Motrin	Motrin	NN	B-NP	O
800	800	CD	I-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
Carafate	Carafate	NN	B-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
and	and	CC	I-NP	O
folate	folate	NN	I-NP	O
.	.	.	O	O

________________________________	________________________________	LS	B-LST	B-cell_type
AB000/8714	AB000/8714	NNP	B-NP	I-cell_type
DARRELL	DARRELL	NNP	I-NP	I-cell_type
PITCAVAGE	PITCAVAGE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AC8	AC8	NNP	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/2/90	5/2/90	CD	B-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
8321	8321	CD	B-NP	O
Report	Report	NNP	I-NP	O
:	:	:	O	O
D9184R24	D9184R24	NN	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/10/90	10/10/90	CD	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
JOESPH	JOESPH	NN	B-NP	O
ZUEHL	ZUEHL	NN	I-NP	O
,	,	,	O	O
M.D	M.D	NN	B-NP	O
.	.	.	O	O

